ClinicalTrials.Veeva

Menu

Cereset Research for Performance Improvement in a Hospital Nursing Unit

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Invitation-only

Conditions

Health Personnel
Insomnia
Depression
Anxiety
Stress

Treatments

Device: Cereset Research

Study type

Interventional

Funder types

Other

Identifiers

NCT06378554
IRB00111227

Details and patient eligibility

About

The purpose of this study is to explore whether an implementation process composed of offering CR to staff in a single hospital nursing unit has any potential impact on unit-level quality measures post-implementation.

Full description

This is a pre-post design quality improvement project and implementation study, evaluating implementation measures, group level quality measures using QI methodology, and individual-level behavioral and performance measures before and after implementation of the Cereset Research (CR) evidence-based intervention among nursing unit staff. Individual-level behavioral symptoms and a nursing performance metric will be evaluated among healthcare workers in the nursing unit in the pre- and post-implementation timeframes among individuals who consent to participate in these evaluation activities. Up to 40 members of the unit will have the opportunity to enroll in the acoustic echoing neurostimulation intervention during the implementation timeframe. The neurostimulation intervention consists of 4 Cereset Research sessions of audible tones echoing current brainwave activity, and individual level behavioral symptoms will be collected following the last intervention session.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ability to comply with basic instructions and be able to sit still, comfortably during sessions.
  • Healthcare worker in the Orthopedic Trauma Unit at Atrium Health Wake Forest Baptist, aged 18 years and older.

Exclusion criteria

  • Unable, unwilling, or incompetent to provide informed consent.
  • Physically unable to come to the study visits.
  • Severe hearing impairment (because CR involves acoustic stimulation that participants would need to be able to hear).
  • Weight is over the chair limit (400 pounds).
  • Currently enrolled in another Cereset Research study.
  • Use of the following modalities within one month before enrollment: electroconvulsive therapy (ECT), prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, eye movement desensitization and reprocessing (EMDR), brain spotting, neurofeedback, biofeedback, or deep brain stimulation (DBS). Individuals will be given the opportunity to discontinue these techniques for one month and then enroll.
  • Known seizure disorder.
  • Thoughts of active suicide within the last 3 months.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Cereset Intervention Group
Active Comparator group
Description:
This system uses the same core technology and algorithms to echo brainwaves in real-time using audible tones, as with High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM).
Treatment:
Device: Cereset Research
No Intervention
No Intervention group
Description:
No Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Charles H Tegeler, MD; Dawn Higgins

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems